Class II
Terminated
Ibuprofen Tablets USP, 400 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-5853-61
Why: cGMP deviations: Temperature abuse
- Company
- Mckesson Medical-Surgical Inc. Corporate Office
Richmond, VA, United States - Reported
- Jun 15, 2022
- Recall started
- Apr 13, 2022
- Ended
- Nov 30, 2023
- Where sold
- USA nationwide.
- Amount
- 1 carton/100 blisters per carton
- Full product description
- Ibuprofen Tablets USP, 400 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-5853-61
- Lots / codes affected
- McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.